Table 1 Clinical data on patients... | American Society of Hematology

Table 1

Clinical data on patients studied

Patient number	Age, y/sex	Lymphocyte count, ×10⁹/L	Rai stage	IgV_H status
1	74/F	68	IV	M
2	80/F	19	IV	U
3	44/M	23	II	U
4	46/F	65	II	M
5	61/M	214	IV	M
6	78/M	47	III	M
7	69/M	25	IV	U
8	84/F	44	III	M
9	85/M	56	I	M
10	60/F	46	II	M
11	58/M	55	II	U
12	76/M	35	III	M
13	53/M	81	III	M
14	66/F	68	0	ND
15	70/F	47	IV	M
16	77/F	96	0	U
17	65/M	84	III	ND
18	84/M	87	IV	M
19	58/M	124	IV	U
20	71/M	22	0	M
21	64/M	36	0	M
22	73/F	47	IV	M
23	40/M	44	IV	U
24	60/F	42	IV	U
25	63/M	56	II	ND
26	75/M	129	IV	U
27	63/F	142	III	U
28	60/F	116	II	U
29	78/F	42	III	U
30	74/M	57	III	U

Patient number	Age, y/sex	Lymphocyte count, ×10⁹/L	Rai stage	IgV_H status
1	74/F	68	IV	M
2	80/F	19	IV	U
3	44/M	23	II	U
4	46/F	65	II	M
5	61/M	214	IV	M
6	78/M	47	III	M
7	69/M	25	IV	U
8	84/F	44	III	M
9	85/M	56	I	M
10	60/F	46	II	M
11	58/M	55	II	U
12	76/M	35	III	M
13	53/M	81	III	M
14	66/F	68	0	ND
15	70/F	47	IV	M
16	77/F	96	0	U
17	65/M	84	III	ND
18	84/M	87	IV	M
19	58/M	124	IV	U
20	71/M	22	0	M
21	64/M	36	0	M
22	73/F	47	IV	M
23	40/M	44	IV	U
24	60/F	42	IV	U
25	63/M	56	II	ND
26	75/M	129	IV	U
27	63/F	142	III	U
28	60/F	116	II	U
29	78/F	42	III	U
30	74/M	57	III	U

ND indicates not determined, M; mutated IgV_H; and U, unmutated IgV_H.